Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ACHV Achieve Life Sciences Inc.
- Stocks
- Healthcare
- NASDAQ: ACHV
Price (delayed)
$2.48
Market cap
$86.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.34
Enterprise value
$82.96M
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company
Highlights
The debt has contracted by 42% YoY
Achieve Life Sciences's equity has shrunk by 79% YoY and by 51% QoQ
ACHV's net income has shrunk by 69% YoY and by 16% QoQ
Key stats
What are the main financial stats of ACHV
Market
Valuations
Earnings
Shares outstanding
34.69M
Market cap
$86.02M
Enterprise value
$82.96M
Price to earnings (P/E)
N/A
Price to book (P/B)
8.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$45.98M
Net income
-$46.16M
EBIT
-$44.61M
EBITDA
-$44.37M
Free cash flow
-$35.57M
Per share
Balance sheet
Liquidity
EPS
-$1.34
EPS diluted
-$1.34
Free cash flow per share
-$1.03
Book value per share
$0.3
Revenue per share
$0
TBVPS
$0.73
Total assets
$27.36M
Total liabilities
$17.08M
Debt
$9.96M
Equity
$10.28M
Working capital
$17.87M
Debt to equity
0.97
Current ratio
3.51
Quick ratio
3.26
Net debt/EBITDA
0.07
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-103.3%
Return on equity
-176.1%
Return on invested capital
-133.5%
Return on capital employed
-220.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACHV stock price
How has the Achieve Life Sciences stock price performed over time
Intraday
-6.42%
1 week
4.2%
1 month
14.29%
1 year
-50.5%
YTD
-29.55%
QTD
-7.12%
Financial performance
How have Achieve Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$45.98M
Net income
-$46.16M
Gross margin
N/A
Net margin
N/A
Achieve Life Sciences's operating income has shrunk by 87% YoY and by 18% QoQ
ACHV's net income has shrunk by 69% YoY and by 16% QoQ
Price vs fundamentals
How does ACHV's price correlate with its fundamentals
Growth
What is Achieve Life Sciences's growth rate over time
Valuation
What is Achieve Life Sciences stock price valuation
P/E
N/A
P/B
8.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Achieve Life Sciences's EPS has decreased by 8% QoQ and by 6% YoY
Achieve Life Sciences's equity has shrunk by 79% YoY and by 51% QoQ
The P/B is 59% less than the 5-year quarterly average of 20.3 but 40% more than the last 4 quarters average of 6.0
Efficiency
How efficient is Achieve Life Sciences business performance
Achieve Life Sciences's return on invested capital has surged by 67% YoY but it has decreased by 3.3% QoQ
Achieve Life Sciences's return on equity has shrunk by 59% QoQ
ACHV's ROA is down by 43% since the previous quarter and by 35% year-on-year
Dividends
What is ACHV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACHV.
Financial health
How did Achieve Life Sciences financials performed over time
The total assets is 60% more than the total liabilities
The total assets has plunged by 61% YoY and by 29% from the previous quarter
The quick ratio fell by 37% QoQ
The debt is 3.1% less than the equity
Achieve Life Sciences's debt to equity has soared by 177% YoY and by 102% from the previous quarter
Achieve Life Sciences's equity has shrunk by 79% YoY and by 51% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.